ACCENDRA HEALTH INC/VA/ 8-K
Research Summary
AI-generated summary
Accendra Health Announces Exchange Offers, New Secured Notes & Credit Amendments
What Happened
Accendra Health, Inc. filed an 8-K on June 15, 2026 reporting that it entered into material definitive agreements to issue new secured notes and launched exchange offers and consent solicitations. The company filed first‑lien and second‑lien indentures dated June 15, 2026 and disclosed forms of global notes for 9.000% Senior Secured Notes due 2032 and 9.750% Senior Secured Notes due 2033. Accendra also filed amendments to its revolving credit and term loan agreements (Amendment No. 4 to the Credit Agreement and Amendment No. 2 to the Term Loan Credit Agreement) and announced early results of the exchange offers in a press release dated June 10, 2026.
Key Details
- New notes: 9.000% Senior Secured Notes due 2032 (first lien) and 9.750% Senior Secured Notes due 2033 (second lien); related indentures and global note forms were filed as exhibits.
- Dates and parties: Indentures dated June 15, 2026 (Regions Bank as trustee/collateral agent); Second Supplemental Indentures dated June 9, 2026 to prior indentures.
- Credit amendments: Amendment No. 4 to the Credit Agreement (Bank of America, N.A. as administrative agent) and Amendment No. 2 to the Term Loan Credit Agreement (JPMorgan Chase Bank, N.A. as administrative agent), each dated June 15, 2026.
- Exchange offers/consents: Early results announced June 10, 2026; offers and consents remain subject to conditions and may be amended or not completed. New Notes and guarantees have not been registered under the U.S. Securities Act and are restricted from U.S. offers/sales except as permitted by law.
Why It Matters
These actions reshape Accendra’s debt structure by adding new secured notes and changing terms of its credit facilities and term loan. For investors, that can affect the company’s interest expense, debt maturities and secured creditor priorities. The company warns the exchange offers are conditional and may not be completed; failure to complete the transactions or unfavorable terms could materially affect Accendra’s financial condition. The filing also includes standard forward‑looking statement cautions.
Loading document...